Insiders · Profile

Turenne Andre

President & CEO at Voyager Therapeutics. Filing since 21 Jan 2020. CIK 0001747102

Company
Date
Role
Action
Shares
Amount
Of holding
11 Feb 2021
President & CEO
Sold, plan not stated
7,977
$60.23K
5.1%
12 Jan 2021
President & CEO
Sold, plan not stated
10,443
$90.02K
6.3%
21 Jan 2020
President & CEO
Sold, plan not stated
10,705
$143.02K
11.1%
3 decisions on file.